Adaptimmune Limited
Adaptimmune is a clinical-stage biopharmaceutical company dedicated to revolutionizing cancer treatment through innovative cell therapy. By harnessing the power of a patient's own cells, Adaptimmune aims to create personalized therapies that specifically target and combat solid tumors.
Founded: 19 Dec 2007
Industries:
72190 - Other research and experimental development on natural sciences and engineering
Website: adaptimmune.com
Phone: +441235430000
Email: dana.lynch@adaptimmune.com
Location: Abingdon
Products & Services
• afami-cel
• cancer immunotherapy
• cell therapy
• lete-cel
• personalized cell therapy development
• research and product development
• solid tumors
• uza-cel
Financial Snapshot
Cash in Bank
Turnover
EBITDA
Gross Profit
Total Liabilities
Employees
Unlock financial data with Pro Start Free Trial →
People
Officers
2
Shareholders
2
Controllers (PSC)
1
Adrian George Rawcliffe
Director • British • Lives in United States • Born in Apr 1972
William Charles Bertrand
Director • American • Lives in United States • Born in Oct 1964
Basic Information
LTD
19 Dec 2007
ENGLAND WALES
Yes
Industry Classification
72190
Company Attributes
N/A
N/A
N/A
N/A
Summary
19
Officers
1
PSCs
0
Filings